StonvexLoading…
StonvexStonvexStonvexCore line items from SAH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $15.15B | $14.22B | $14.37B | $14.00B |
Operating Income | $367.50M | $461.50M | $423.60M | $314.00M |
Net Income | $118.70M | $216.00M | $178.20M | $88.50M |
EPS (Diluted) | $3.42 | $6.18 | $4.97 | $2.23 |
Total Assets | $5.97B | $5.90B | $5.36B | $4.98B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $6.30M | $44.00M | $28.90M | $229.20M |
Free Cash Flow OCF − CapEx | $417.50M | $-78.10M | $-219.30M | $179.00M |
Shares Outstanding | 34.70M | 35.00M | 35.90M | 39.70M |